Cardiovascular safety of weight loss drug examined

29 Aug 2018


Research, published in The New England Journal of Medicine, shows that weight loss drug Lorcaserin does not cause heart valve disease.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story